Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The London-based generic drug company Hikma Pharmaceuticals has agreed to acquire Boehringer Ingelheim’s U.S. injectable generic drug business for $225 million plus up to $75 million in milestone payments. Hikma also has an option to acquire Boehringer’s Ben Venue Laboratories facility in Bedford, Ohio. The plant, one of the largest sterile injectables manufacturing sites in the world, closed at the end of 2013 after a struggle with drug quality problems. Hikma plans to bring back products that were made in the Ohio plant by transferring output to its own facilities.
This article has been sent to the following recipient: